US 8933080
Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
granted A61KA61K31/502A61P
Quick answer
US patent 8933080 (Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/502, A61P, A61P13/12, A61P15/00